NEW YORK – Novacyt said on Monday that it has partnered with German company BioType Diagnostic to manufacture its COVID-19 test. Under the agreement, BioType, based in Dresden, has delivered the first batches of products for final assembly to Primerdesign, Novacyt's UK-based molecular diagnostics division.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.